Insights from Industry RSS Feed - Insights from Industry

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Trifocal lenses: the best chance of true spectacle independence?

Trifocal lenses: the best chance of true spectacle independence?

Trifocal intraocular lenses (IOLs) represent the latest in premium lens technology. They are tiny, artificial lenses that are implanted into the eye during a cataract or lens replacement procedure. [More]
Super-resolution imaging of biological specimens: an interview with Dr. Manasa Gudheti

Super-resolution imaging of biological specimens: an interview with Dr. Manasa Gudheti

Traditional light microscopy techniques such as confocal and wide-field are diffraction-limited in resolution, which is about 200 nm laterally (in xy) and 500 to 600 nm axially (in z). Features that are closer than the diffraction limit will appear blurred in the image. [More]
Are migraines genetic? An interview with Nick Furlotte

Are migraines genetic? An interview with Nick Furlotte

There's a big debate right now in the migraine community around the underlying cause of the disease. The question is whether it is vascular, and has something to do with our vessels, or whether it has to do with our neurons not functioning correctly or misfiring. [More]
Color-deficiency or color-blindness?

Color-deficiency or color-blindness?

Color blindness could be considered a bit of a misleading term, because there are very few people who can't see color at all. Most people have what we call color deficiency or color confusion, which means that they're not blind to color; they just see a reduced number of colors. [More]
Food intolerance testing: an interview with Dr Gill Hart

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances. [More]
Using the immune system to fight cancer: an interview with Dr Charles Akle

Using the immune system to fight cancer: an interview with Dr Charles Akle

We all produce as many as 100,000 different types of cancer cells every day, which are recognized and eliminated by our extraordinarily efficient immune system. However, if something goes wrong with the immune system, and it no longer gets rid of these cells, then that’s when cancerous cells grow and become a problem. [More]
Advances in human genotyping arrays: an interview with Rob Brainin

Advances in human genotyping arrays: an interview with Rob Brainin

Illumina sees a widespread demand for genotyping products and a continued relevance of arrays in human disease and translational research. [More]
Neuroimaging: an insight into psychiatric causes? An interview with Dr Craig Buckley

Neuroimaging: an insight into psychiatric causes? An interview with Dr Craig Buckley

CUBRIC is one of the top neuroimaging research centres in the UK and has grown rapidly since it opened in 2006. CUBRIC is expected to become an international hub for neuroimaging, unique in Europe. [More]
Using biomarkers to diagnose sepsis: an interview with Jordi Trafi

Using biomarkers to diagnose sepsis: an interview with Jordi Trafi

Sepsis, according to the new clinical definition of sepsis, is organ dysfunction caused by the body’s dysregulated response to an infection. Sepsis is common, with about 20 million patients/year in the developed world. It can escalate to septic shock, which is a life-threatening condition with a mortality rate of about 40%. In fact, about every second someone in the world dies of sepsis. [More]
Advances in nuclear medicine production: an interview with Jayne Senior

Advances in nuclear medicine production: an interview with Jayne Senior

In my view, one of the greatest changes in recent history that has come about in nuclear medicine production is Australia’s full adoption of Low-Enriched Uranium (LEU) technologies – in both the fuel and the target plates. [More]
Specialty pharmaceuticals: an interview with David Moran, Clinigen SP

Specialty pharmaceuticals: an interview with David Moran, Clinigen SP

Specialty pharmaceuticals as a category has its origins in the 1970s with complex treatments being developed for disease areas such as cancer, HIV and haemophilia and what characterises a specialty pharmaceutical product is that it will be high touch, high complexity or high cost and is often associated with the treatment of rare or orphan conditions. These products require a considerable amount of expertise, innovation and technology and can be expensive as a result. [More]
Preimplantation genetic screening using next generation sequencing: an interview with Dr Luis Alcaraz

Preimplantation genetic screening using next generation sequencing: an interview with Dr Luis Alcaraz

PGS, Preimplantation Genetic Screening, is a genetic test that analyses biopsied cells from embryos produced by in vitro fertilization (IVF) techniques. PGS determines whether the embryos are chromosomally normal (euploid) or not (aneuploid), thus giving the chance to transfer chromosomally normal embryos that are more apt to successfully implant and develop into a pregnancy. [More]
Next generation wearables for health monitoring: an interview with Dr Steven LeBoeuf

Next generation wearables for health monitoring: an interview with Dr Steven LeBoeuf

Wearables have proliferated in the marketplace, but there's still a lot of opportunity for growth. One of the ways in which wearables are limited is that people expect their wearables to really measure what they feel is important to be measured [More]
Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin was one of the first antibiotics developed and has saved millions of lives. First used in the early 1940s, penicillin is still one of the most widely used and least toxic family of antibiotics. [More]
Interactive touch display systems in healthcare: an interview with Peter Holgate

Interactive touch display systems in healthcare: an interview with Peter Holgate

The MultiTaction solution is the most advanced visualisation and engagement platform in the market today. Our unique hardware and software solution provides users with a compelling interactive experience as they engage with various forms of content. For this reason, the MultiTaction displays are used in many different showcase environments across the world; from Museums, Universities and Marketing Suites through to events and exhibitions. [More]
Immunotherapy innovations in oncology: an interview with Robert LaCaze

Immunotherapy innovations in oncology: an interview with Robert LaCaze

The body’s immune system is an excellent weapon against many diseases. For more than 100 years, immunology and immunotherapy have played an ever-increasing role in the understanding and treatment of cancer. [More]
Battling IBD with super heroes: an interview with Dr James Lindsay

Battling IBD with super heroes: an interview with Dr James Lindsay

Takeda Pharmaceutical Company Limited has launched IBD Unmasked as a first-of-its-kind global initiative designed to raise awareness of the unsung Super Heroes of the global IBD community. [More]
Overcoming gene silencing barriers to target neurological conditions: an interview with Dr Errol de Souza

Overcoming gene silencing barriers to target neurological conditions: an interview with Dr Errol de Souza

Many gene mutations that cause neurological disorders have been identified. For example, in a rare neurological disorder such as Huntington’s disease, an autosomal dominant mutation through expansion of CAG (cytosine-adenine-guanine) triplet repeats in the gene coding for the Huntingtin protein results in abnormal protein production. [More]
Cancer risk screening for hereditary mutations: an interview with Ted Snelgrove

Cancer risk screening for hereditary mutations: an interview with Ted Snelgrove

Great question – the answer is actually unknown. Every month, there are publications that report on new cancer-related genes, so it's an area of great knowledge growth at the moment. [More]
Self-care: achieving accessibility safely. An interview with Zephanie Jordan

Self-care: achieving accessibility safely. An interview with Zephanie Jordan

Self-care can be broadly defined to include measures taken by an individual in the pursuit of obtaining or maintaining good health. It ranges from healthy eating and exercise to good hygiene practices to appropriate use of products such as dietary supplements and over-the-counter medicines to accessing health promoting services. [More]
Advertisement
Advertisement